01-014 · EVIDENCE A · SOURCE-SENSITIVE

Get tested for hepatitis B markers; if no antibodies, get vaccinated

查乙肝两对半,没有抗体就打疫苗

Source cost

The test costs just a few dozen yuan per person. For adults lacking antibodies, three doses of the hepatitis B vaccine cost between 100 and 300 yuan total, to be completed within six months.

Source return

The test itself is very inexpensive. In Qidong’s 30‑year follow‑up study, infants who received the hepatitis B vaccine at birth had an 84% lower risk of developing primary liver cancer and a 72% lower rate of carrying the hepatitis B virus compared to unvaccinated peers. Adults found to have no antibodies should receive three vaccine doses over six months at a cost of roughly 100–300 yuan.

Evidence grade

A

THE LOW-ROI DETOURSatire, not advice

Move “Get tested for hepatitis B markers; if no antibodies, get vaccinated” to Future Me's calendar

The excuse

There is no immediate alarm, so the sensible choice can wait for a less busy week.

What feels good now

Today I keep a little money, a few minutes and avoid interrupting my default routine.

What the source says

The source summarizes the return this way: “The test itself is very inexpensive. In Qidong’s 30‑year follow‑up study, infants who received the hepatitis B vaccine at birth had an 84% lower risk of developing primary liver cancer and a 72% lower rate of carrying the hepatitis B virus compared to unvaccinated peers. Adults found to have no antibodies should receive three vaccine doses over six months at a cost of roughly 100–300 yuan.” Evidence grade A. The original states the population, caveats, and sources; this is not a personal forecast.

THE ENGLISH EDITION

Original recommendation and evidence

Source commit a994b6a0c905

14. Get tested for hepatitis B markers; if no antibodies, get vaccinated

Cost: The test costs just a few dozen yuan per person. For adults lacking antibodies, three doses of the hepatitis B vaccine cost between 100 and 300 yuan total, to be completed within six months.

In plain terms: The test itself is very inexpensive. In Qidong’s 30‑year follow‑up study, infants who received the hepatitis B vaccine at birth had an 84% lower risk of developing primary liver cancer and a 72% lower rate of carrying the hepatitis B virus compared to unvaccinated peers. Adults found to have no antibodies should receive three vaccine doses over six months at a cost of roughly 100–300 yuan.

Benefit: This Qidong trial used group randomization rather than individual assignment and was tracked for three decades. Vaccination at birth cut primary liver cancer incidence by 84% (95% CI 23%–97%). The prevalence of hepatitis B surface antigen (HBsAg) fell by 72% (95% CI 68%–75%), reflecting a comparable drop in the proportion of people carrying the virus. Nationwide in China, HBsAg prevalence dropped 52% between 1992 and 2014, and fell 97% among children under five.

Evidence grade: A

Sources: Qu C et al. (2014). Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study. PLoS Medicine. <https://doi.org/10.1371/journal.pmed.1001774>; Cui F et al. (2017). Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerging Infectious Diseases. <https://doi.org/10.3201/eid2305.161477>

Notes: This recommendation applies to adults born before 1992 who never received the vaccine or whose antibodies have waned. The 84% cancer‑risk reduction pertains only to those immunized at birth; adolescents vaccinated later saw only a 21% reduction in virus carriage. For adults, the main goal is preventing new infection, not achieving the same cancer‑prevention benefit. Vaccination offers no protection to people already infected; they must see a hepatologist regularly. Infection is confirmed when the hepatitis B surface antigen (HBsAg) test result is positive.

Read the complete Chinese source and notes

14. 查乙肝两对半,没有抗体就打疫苗

成本: 查一次几十元。成人乙肝疫苗 3 针合起来 100 到 300 元。半年之内打完。

说人话: 查一次几十块。启东那项跟踪了 30 年的试验里,一出生就打了乙肝疫苗的人,后来得原发性肝癌的概率低 84%,身上带着乙肝病毒的比例低 72%。成人查出没抗体的补三针,半年打完,一两百块。

收益: 启东那项试验按群体随机分组,不是按个人分组,跟踪了 30 年。新生儿接种乙肝疫苗,原发性肝癌下降 84%。可信范围是 95% CI 23% 到 97%。乙肝表面抗原 HBsAg 阳性率下降 72%(95% CI 68% 到 75%),这个阳性率就是查出身上带着病毒的人所占的比例。中国全人群的 HBsAg 阳性比例,1992 到 2014 年下降 52%,5 岁以下下降 97%

证据等级: A

来源: Qu C 等 (2014). Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study. PLoS Medicine. <https://doi.org/10.1371/journal.pmed.1001774> ; Cui F 等 (2017). Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerging Infectious Diseases. <https://doi.org/10.3201/eid2305.161477>

备注: 这条适用于 1992 年前出生、没打过疫苗或者抗体已经消失的成人。肝癌下降 84% 那个数来自一出生就打的人。同一项试验里,到青少年才补打的,防住病毒携带的效力只有 21%。成人打主要图的是不再被感染,不能直接套那个 84%。已经感染的人打疫苗没用,要去肝病科定期复查。怎么算已经感染:化验单上乙肝表面抗原 HBsAg 那一项是阳性。

Author's scope notes: 这条适用于 1992 年前出生、没打过疫苗或者抗体已经消失的成人。肝癌下降 84% 那个数来自一出生就打的人。同一项试验里,到青少年才补打的,防住病毒携带的效力只有 21%。成人打主要图的是不再被感染,不能直接套那个 84%。已经感染的人打疫苗没用,要去肝病科定期复查。怎么算已经感染:化验单上乙肝表面抗原 HBsAg 那一项是阳性。

YOUR PRIVATE LIST

Choose what to do with this idea

Original content by eternity4719 under CC BY 4.0. English translation is credited in the source notes. HowToLiveWorse adds a clearly labeled satirical response.

Full source and adaptation notes